Dextra Continuation Opportunities LP is a private equity fund based in New York, New York. According to its most recent Form D, filed Feb 26, 2026, it has sold $133,000,000 of interests to 3 investors since its first sale in Sep 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Scott Iorio; A. Palkar; James Barker, V.
- Total raised
- $133,000,000Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Sep 26, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Scott Iorio; A. Palkar; James Barker, V
- Latest Form D
- Feb 26, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Dextra Continuation Opportunities LP
What is the minimum investment for Dextra Continuation Opportunities LP?
Dextra Continuation Opportunities LP's latest Form D, filed Feb 26, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Dextra Continuation Opportunities LP?
Dextra Continuation Opportunities LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Dextra Continuation Opportunities LP raised?
Dextra Continuation Opportunities LP reports $133,000,000 sold from 3 investors on its Form D filed Feb 26, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Dextra Continuation Opportunities LP based?
Dextra Continuation Opportunities LP is based in New York, New York.
When did Dextra Continuation Opportunities LP launch?
Dextra Continuation Opportunities LP reports its first sale in Sep 2025.
Size compared with every private equity fund
Raised more than 80% of the 3,653 private equity funds based in New York, and more than 76% of all 8,842 that report sales.